Zhengfei Zhu

25PUBLICATIONS
71CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation therapyMolecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Aug 18, 2026
Synergistic effects and clinical utilization of radioimmunotherapy for brain metastases from driver mutation-negative non-small cell lung cancer.

|Apr 29, 2026
Identification of a distinct cluster of LY6E+ macrophages in esophageal squamous cell carcinoma: functional phenotype, spatial interaction, and prognostic significance.

|Sep 26, 2025
Radiation-induced extracellular vesicles from cancer-associated fibroblasts drive oesophageal squamous cell carcinoma metastasis via the miR-193a-3p/PTEN/Akt pathway.

Yechun Pang, Tiantian Guo, Yue Zhou

|Aug 01, 2025
Consolidative stereotactic radiotherapy for oligo-residual non-small cell lung cancer after first-line chemoimmunotherapy: A single-arm, phase 2 trial from China.

Hongru Chen, Lu Yu, Fei Liang

|Mar 07, 2025
Radiation Dose-Volume Effects on Negative Tumor-Draining Lymph Nodes Affected T-cell Activation and Prognosis in Esophageal Cancer with Chemoradiotherapy.

Ihsuan Tseng, Yun Chen, Dashan Ai

|Aug 22, 2024
Sintilimab in combination with stereotactic body radiotherapy and granulocyte-macrophage colony-stimulating factor in metastatic non-small cell lung cancer: The multicenter SWORD phase 2 trial.

Jianjiao Ni, Xiaofei Wang, Lin Wu

Pageof 5

Frequent Collaborators

4 joint publications

Gen Lin

4 joint publications

Zhansheng Jiang

4 joint publications

Chunwei Xu

4 joint publications

Wenxian Wang